ATS Medical

ATS Medical to Participate at the Rodman & Renshaw Annual Global Investment Conference

PR News Wire (Free subscription) | 11/05/2008

MINNEAPOLIS, Nov. 5 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ), manufacturer and marketer of state-of-the-art cardiac surgery products, announced today that it will participate at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel. Michael Kramer, Chief Financial Officer of ATS Medical, will present at 10:45 a.m. Eastern Time on Monday, November...

ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis

PR News Wire (Free subscription) | 10/30/2008

MINNEAPOLIS, Oct. 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received U.S. Food and Drug Administration (FDA) approval for the ATS 3f(R) Aortic Bioprosthesis. (Logo: ) This is the Company's first entry into the $400-plus Million U.S. tissue valve market. Based on the...

ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call

The Earth Times Online Newspaper (Free subscription) | 10/28/2008

MINNEAPOLIS, Oct. 28 -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that it will release financial results for the third quarter ended Sep...

ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call

PR News Wire (Free subscription) | 10/28/2008

MINNEAPOLIS, Oct. 28 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that it will release financial results for the third quarter ended September 27, 2008 after the market close on Monday, November 3, 2008. The Company will host a conference call and webcast on Monday, November 3, 2008...

• ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call - The Earth Times Online Newspaper

ATS Medical to Participate at the Natixis Bleichroeder Second Annual Hidden Gems Conference

PR News Wire (Free subscription) | 10/09/2008

MINNEAPOLIS, Oct. 9 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ), manufacturer and marketer of state-of-the-art cardiac surgery products, announced today that it will participate at the Second Annual Natixis Bleichroeder Hidden Gems Conference at the Waldorf Astoria in New York. Michael Dale, President and CEO of ATS Medical, will present at 9:30 a.m. Eastern Time on Monday,...

ATS Forcefield Anti-platelet Technology Continues To Demonstrate Positive Results

Medical News Today (Free subscription) | 11/04/2008

ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced completion of the final feasibility milestone in the development of the ATS Forcefield(TM) technology. The animal feasibility study has been completed with positive results regarding the inhibition of platelet adhesion on mechanical heart valve prostheses.

Dr. James Cox, Medical Director for ATS Medical, To Present at TCT Surgeon Session

PR News Wire (Free subscription) | 10/10/2008

MINNEAPOLIS, Oct. 10 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that Dr. James Cox, the ATS Medical Director, will make two presentations at the upcoming Transcatheter Cardiovascular Therapeutics Symposium (TCT) on Tuesday, October 14, 2008 in Washington, DC. The TCT Symposium includes...